Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8215882 | 0.83 | — | — | |
| SCHEMBL7744145 | 0.82 | LMNA (0.38) | TSHR | |
| SCHEMBL26977393 | 0.79 | TSHR (0.36) | TSHR | |
| SCHEMBL8217378 | 0.79 | — | — | |
| SCHEMBL2771614 | 0.79 | — | — | |
| SCHEMBL19162410 | 0.79 | — | — | |
| SCHEMBL8220280 | 0.78 | — | — | |
| SCHEMBL21166409 | 0.78 | — | — | |
| SCHEMBL8219254 | 0.77 | — | — | |
| SCHEMBL20797141 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3317268-B1 | HERBICIDALLY ACTIVE N-(TETRAZOL-5-YL)- AND N-(TRIAZOL-5-YL)ARYLCARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2019-08-28 | — | — | EP | disclosed |
| EP-2170855-B1 | C10 ALKANOIC ACID GLYCIDYL ESTERS AND USE THEREOF | BASF SE (DE) | 2012-08-08 | — | — | EP | disclosed |
| US-20100180802-A1 | C10 ALKANOIC ACID GLYCIDYL ESTERS AND USE THEREOF | BASF SE (DE) | 2010-07-22 | — | — | US | disclosed |
| EP-2170855-A1 | C10 ALKANOIC ACID GLYCIDYL ESTERS AND USE THEREOF | BASF SE (DE) | 2010-04-07 | — | — | EP | disclosed |
| WO-2009000839-A1 | C10 ALKANOIC ACID GLYCIDYL ESTERS AND USE THEREOF | BASF SE (DE) | 2008-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100180802-A1 | C10 ALKANOIC ACID GLYCIDYL ESTERS AND USE THEREOF | ALKBH3, ALK, ALKBH1 | TSHR 2447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.